FDA Approved: MAXALT — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental application for MAXALT (rizatriptan benzoate) submitted by Organon LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Maxalt (Rizatriptan)

Snippet

SUPPL AP for MAXALT (RIZATRIPTAN BENZOATE)